PFE
32
4
JCI
54
2
WBA
67
4
PDCO
46
3
NRG
65
5
VLO
30
2
FCX
63
2
ZTS
49
2
T
51
6
LUV
43
4
HRL
30
3
GRMN
48
2
EMC
68
6
MSFT
48
-3
EA
31
-3
PNR
66
3
AES
37
4
CVX
32
3
GS
76
4
STI
19
12
PFE
32
4
JCI
54
2
WBA
67
4
PDCO
46
3
NRG
65
5
VLO
30
2
FCX
63
2
ZTS
49
2
T
51
6
LUV
43
4
HRL
30
3
GRMN
48
2
EMC
68
6
MSFT
48
-3
EA
31
-3
PNR
66
3
AES
37
4
CVX
32
3
GS
76
4
STI
19
12
Financhill
Back

ProShares Short FTSE China 50 Vs. Kymera Therapeutics Industry Stock Comparison

Sell
41

YXI
ProShares Short FTSE China 50

Last Price:
13.69
Seasonality Move:
-3.96%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
48.99
Seasonality Move:
65.72%
Sell
41
ProShares Short FTSE China 50 (YXI) is a Sell

Is ProShares Short FTSE China 50 a Buy, Sell or Hold?

  • The current ProShares Short FTSE China 50 [YXI] share price is $13.73. The Score for YXI is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • YXI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

YXI Stock Price Chart

What is ProShares Short FTSE China 50's stock price today?

  • The ProShares Short FTSE China 50 share price today is $13.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and YXI is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

YXI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 42.53 Sell
Chaikin Money Flow: 1967 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.71 - 16.45) Sell
Bollinger Bands (100): (15.06 - 18.1) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

YXI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.17 Buy
20-day SMA: 13.87 Sell
50-day SMA: 16.01 Sell
200-day SMA: 17.74 Sell
8-day EMA: 13.43 Buy
20-day EMA: 14.02 Sell
50-day EMA: 15.36 Sell
200-day EMA: 17.05 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

ProShares Short FTSE China 50 Earnings Growth & YXI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

ProShares Short FTSE China 50 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):